BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Antiphospholipid syndrome (APS) is a rare autoimmune disease characterized by arterial,
venous, or microvascular thrombosis, pregnancy morbidities, or nonthrombotic …

Background Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …

Despite the increasing burden of ill health attributable to chronic kidney disease, appropriate
pharmacotherapy has been inadequate. Based on trials in the 1990s and 2000s, 1 …

Venous thromboembolism (VTE) is a leading cause of maternal morbidity and mortality
worldwide. Despite the impact of VTE on pregnant and postpartum people and on society …

Low-molecular-weight heparin (LMWH), derived from unfractionated heparin (UFH), has
enhanced anticoagulant efficacy, long duration of action, and extended half-life. Patients …

Objective Social exclusion (such as that experienced by people who are homeless,
incarcerated or use drugs) increases morbidity across a range of diseases but is poorly …

Background Peripartum management of women using low-molecular-weight heparin
(LMWH) varies widely. Minimum time intervals are required between LMWH injection and …

Venous thromboembolism (VTE) remains the leading cause of maternal mortality in
pregnancy and the postpartum period. In addition to the higher pregnancy-associated …

Background The Society of Australia and New Zealand (SOMANZ) published its first sepsis
in pregnancy and the postpartum period guideline in 2017 (Aust NZJ Obstet Gynaecol, 57 …